Co-Located Conference AgendasNovel Formulation Strategies | QbD in Pharma Development World Congress 2017 | 
Thursday, 20 April 2017 |
Agenda |
| | 08:00 | Registration | 10:00 | Inauguration | 10:10 | Welcome Address by MD SELECTBIO | 10:15 |  | Guest of Honour Inaugural Address
P B N Prasad, Deputy Drugs Controller (India), Central Drugs Standard Control Organization, India
|
| 10:45 | Coffee Break | |
Session 1: QbD for Holistic Pharma Development |
| | 11:15 |  | Keynote Presentation QbD for Holistic Pharma Development: Excellence Precedes Compliance
Bhupinder Singh Bhoop, Dean, UIPS, Panjab University, India
|
| 12:05 | A Holistic Approach of QbD in Pharmaceutical Industry
Korupoju Srinivasa Rao, Director-QbD PharmaSolutions, Piramal Enterprises Limited, India
| 12:50 | Poster Viewing | 13:00 | Lunch Break | |
Session 2: QbD in API Development and Manufacturing |
| | 14:00 | QbD in API Manufacturing Process: Strategy for Successful timely Regulatory Approval using QbD
Sushil Srivastava, Process Research and Development Director, Bristol-Myers Squibb, United States of America
| 14:40 | QbD in API Development: A Luxury or Necessity?
Dhileep Krishnamurthy, CSO, Zhejiang NHU Company Ltd, China
| 15:20 | Coffee Break | |
Session 3: QbD in Analytical Development |
| | 15:40 | Quality by Design – Application to Analytical Method Development
Mrunal Jaywant, Senior Director, USP India Private Limited, India
| 16:20 | Quality by Design in Analytical Method Development
Gautam Samanta, Vice President - Quality by Design and Process Scale-up, Cipla Ltd, India
| 17:00 | Panel Discussion : QbD Implementation: Current Status and Regulatory Perspective | 17:40 | End of First Day of Conference |
Friday, 21 April 201709:30 | “QbD Driven Technology Transfer: An Overview of Some of the Elements, Nuances and Challenges in the Industry”
Shib Mookherjea, Senior Director, ValQual International, United States of America
| 10:30 | Coffee Break | |
Session 4: Enhanced Product and Process Understanding for QbD |
| | 11:00 | PAT for Pharmaceutical Applications: Enhanced Product and Process Comprehension in Manufacturing Sciences
Suresh Kumar, Team Lead, Novartis, India
| 11:40 | Application of Multivariate Tools and Artificial Neural Networking in Science Based Development of Novel Drug Products in PAT and QbD Era
Asha Patel, Associate Professor, Parul University, India
| |
Session 5: DoE as the Pivot in QbD Implementation |
| | 12:20 | Successful DOE/QBD in Generic Pharma Industries
Quaisar Anwar, Assistant Vice President, Recipharm Pharmaservices Pvt. Ltd, India
| 13:00 | 'Understanding DOE - Strategies for Success and Pitfalls to Avoid
Nalini Shastri, Associate Professor, National Institute of Pharmaceutical Education and Research, India
| 13:40 | Lunch Break | |
Session 6: QbD in Developing Formulations and Biologics |
| | 14:40 | Quality by Design (QbD) for Formulation Development
Devendra Ridhurkar, Senior Scientist, Egis Pharmaceuticals, Hungary
| 15:20 | Application of QbD Principles in Biologics Drug Product Development
Satish Singh, Head, Lonza Inc, Switzerland
| 16:00 | QbD in BA/BE
Neerja Somyajee, Manager, Anacipher Clinical Research, India
| 16:40 | Poster Presentation Award | 16:45 | Closing Remarks and Vote of Thanks | 17:00 | End of Conference |
|
Add to Calendar ▼2017-04-20 00:00:002017-04-21 00:00:00Europe/LondonQbD in Pharma Development World Congress 2017QbD in Pharma Development World Congress 2017 in HyderabadHyderabadSELECTBIOenquiries@selectbiosciences.com